Acorda Therapeutics (ACOR) Misses Q2 EPS by $2.79
Tweet
Share
E-mail
Get Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Net loss per share-diluted (earnings per share): -0.28
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net loss per share-diluted (earnings per share): -0.28
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q2 EPS of ($3.15), $2.79 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $18.2 million versus the consensus estimate of $29.1 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
